Rankl Impairs Lactogenic Differentiation Through Inhibition of the Prolactin/Stat5 Pathway at Midgestation

Stem Cells

Volumn 34, Issue 4, 2016, Pages 1027-1039

  Cordero, Alex ^a   Pellegrini, Pasquale ^a   Sanz Moreno, Adrián ^a   Trinidad, Eva M ^a   Serra Musach, Jordi ^a   Deshpande, Chetan ^b   Dougall, William C ^c   Pujana, Miguel Angel ^a   González Suárez, Eva ^a  

^a BELLVITGE BIOMEDICAL RESEARCH INSTITUTE IDIBELL   (Spain)

^b AMGEN INC   (United States)

^c AMGEN INC   (United States)

Author keywords

Mammary alveoli; p Stat5; Progesterone; Prolactin; Rank; Rankl

Indexed keywords

MILK PROTEIN; OSTEOCLAST DIFFERENTIATION FACTOR; PROLACTIN; STAT5 PROTEIN; STAT5A PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ELF5; UNCLASSIFIED DRUG; DNA BINDING PROTEIN; ELF5 PROTEIN, MOUSE; JAK2 PROTEIN, MOUSE; JANUS KINASE 2; PROGESTERONE; TNFSF11 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BREAST CELL; BREAST EPITHELIUM CELL; CELL DIFFERENTIATION; CONTROLLED STUDY; FEMALE; FIRST TRIMESTER PREGNANCY; GENE EXPRESSION; IMMUNOFLUORESCENCE; LACTATION; MAMMARY ACINAR CELL; MAMMARY ALVEOLAR CELL; MILK PRODUCTION; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; ANIMAL; BIOSYNTHESIS; CELL PROLIFERATION; GENE EXPRESSION REGULATION; GENETICS; GROWTH, DEVELOPMENT AND AGING; KNOCKOUT MOUSE; PREGNANCY; SECRETION (PROCESS); SIGNAL TRANSDUCTION; UDDER;

ANIMALS; CELL DIFFERENTIATION; CELL PROLIFERATION; DNA-BINDING PROTEINS; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; JANUS KINASE 2; LACTATION; MAMMARY GLANDS, ANIMAL; MICE; MICE, KNOCKOUT; PREGNANCY; PROGESTERONE; PROLACTIN; RANK LIGAND; SIGNAL TRANSDUCTION; STAT5 TRANSCRIPTION FACTOR; TRANSCRIPTION FACTORS;

EID: 84954304973     PISSN: 10665099     EISSN: 15494918     Source Type: Journal    
DOI: 10.1002/stem.2271     Document Type: Article

References (43)

1. Brisken C,. Hormonal control of alveolar development and its implications for breast carcinogenesis. J Mammary Gland Biol Neoplasia 2002; 7: 39-48.
2. Neville MC, McFadden TB, Forsyth I,. Hormonal regulation of mammary differentiation and milk secretion. J Mammary Gland Biol Neoplasia 2002; 7: 49-66.
3. Brisken C, Park S, Vass T, et al., A paracrine role for the epithelial progesterone receptor in mammary gland development. Proc Natl Acad Sci USA 28 1998; 95: 5076-5081.
4. Mulac-Jericevic B, Lydon JP, DeMayo FJ, et al., Defective mammary gland morphogenesis in mice lacking the progesterone receptor B isoform. Proc Natl Acad Sci USA 19 2003; 100: 9744-9749.
5. Lydon JP, DeMayo FJ, Funk CR, et al., Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities. Genes Dev 1995; 9: 2266-2278.
6. Ormandy CJ, Camus A, Barra J, et al., Null mutation of the prolactin receptor gene produces multiple reproductive defects in the mouse. Genes Dev 1997; 11: 167-178.
7. Oakes SR, Naylor MJ, Asselin-Labat ML, et al., The Ets transcription factor Elf5 specifies mammary alveolar cell fate. Genes Dev 2008; 22: 581-586.
8. Yamaji D, Na R, Feuermann Y, et al., Development of mammary luminal progenitor cells is controlled by the transcription factor STAT5A. Genes Dev 2009; 23: 2382-2387.
9. Gouilleux F, Wakao H, Mundt M, et al., Prolactin induces phosphorylation of Tyr694 of Stat5 (MGF), a prerequisite for DNA binding and induction of transcription. EMBO J 1994; 13: 4361-4369.
10. Horseman ND, Zhao W, Montecino-Rodriguez E, et al., Defective mammopoiesis, but normal hematopoiesis, in mice with a targeted disruption of the prolactin gene. EMBO J 1997; 16: 6926-6935.
11. Teglund S, McKay C, Schuetz E, et al., Stat5a and Stat5b proteins have essential and nonessential, or redundant, roles in cytokine responses. Cell 1998; 93: 841-850.
12. Wagner KU, Krempler A, Triplett AA, et al., Impaired alveologenesis and maintenance of secretory mammary epithelial cells in Jak2 conditional knockout mice. Mol Cell Biol 2004; 24: 5510-5520.
13. Zhou J, Chehab R, Tkalcevic J, et al., Elf5 is essential for early embryogenesis and mammary gland development during pregnancy and lactation. EMBO J 2005; 24: 635-644.
14. Asselin-Labat ML, Vaillant F, Sheridan JM, et al., Control of mammary stem cell function by steroid hormone signalling. Nature 2010; 465: 798-802.
15. Beleut M, Rajaram RD, Caikovski M, et al., Two distinct mechanisms underlie progesterone-induced proliferation in the mammary gland. Proc Natl Acad Sci USA 2010; 107: 2989-2994.
16. Joshi PA, Jackson HW, Beristain AG, et al., Progesterone induces adult mammary stem cell expansion. Nature 2010; 465: 803-807.
17. Fata JE, Kong YY, Li J, et al., The osteoclast differentiation factor osteoprotegerin-ligand is essential for mammary gland development. Cell 2000; 103: 41-50.
18. Fernandez-Valdivia R, Mukherjee A, Ying Y, et al., The RANKL signaling axis is sufficient to elicit ductal side-branching and alveologenesis in the mammary gland of the virgin mouse. Dev Biol 2009; 328: 127-139.
19. Gonzalez-Suarez E, Branstetter D, Armstrong A, et al., RANK overexpression in transgenic mice with mouse mammary tumor virus promoter-controlled RANK increases proliferation and impairs alveolar differentiation in the mammary epithelia and disrupts lumen formation in cultured epithelial acini. Mol Cell Biol 2007; 27: 1442-1454.
20. Pellegrini P, Cordero A, Gallego MI, et al., Constitutive activation of RANK disrupts mammary cell fate leading to tumorigenesis. Stem Cells 2013; 31: 1954-1965.
21. Srivastava S, Matsuda M, Hou Z, et al., Receptor activator of NF-κB ligand induction via Jak2 and Stat5a in mammary epithelial cells. J Biol Chem 2003; 278: 46171-46178.
22. Obr AE, Grimm SL, Bishop KA, et al., Progesterone receptor and Stat5 signaling cross talk through RANKL in mammary epithelial cells. Mol Endocrinol 2013; 27: 1808-1824.
23. Gonzalez-Suarez E, Jacob AP, Jones J, et al., RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis. Nature 2010; 468: 103-107.
24. Smalley MJ,. Isolation, culture and analysis of mouse mammary epithelial cells. Methods Mol Biol 2010; 633: 139-170.
25. de la Cruz L, Steffgen K, Martin A, et al., Apoptosis and involution in the mammary gland are altered in mice lacking a novel receptor, beta1,4-Galactosyltransferase I. Dev Biol 2004; 272: 286-309.
26. Lee GY, Kenny PA, Lee EH, et al., Three-dimensional culture models of normal and malignant breast epithelial cells. Nat Methods 2007; 4: 359-365.
27. Stingl J, Eirew P, Ricketson I, et al., Purification and unique properties of mammary epithelial stem cells. Nature 2006; 439: 993-997.
28. Debnath J, Muthuswamy SK, Brugge JS,. Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures. Methods 2003; 30: 256-268.
29. Anderson SM, Rudolph MC, McManaman JL, et al., Key stages in mammary gland development. Secretory activation in the mammary gland: It's not just about milk protein synthesis! Breast Cancer Res 2007; 9: 204.
30. Barcellos-Hoff MH, Aggeler J, et al., Functional differentiation and alveolar morphogenesis of primary mammary cultures on reconstituted basement membrane. Development 1989; 105: 223-235.
31. Lim E, Wu D, Pal B, et al., Transcriptome analyses of mouse and human mammary cell subpopulations reveal multiple conserved genes and pathways. Breast Cancer Res 2010; 12: R21.
32. Nevins JR,. E2F: A link between the Rb tumor suppressor protein and viral oncoproteins. Science 1992; 258: 424-429.
33. Haricharan S, Li Y,. STAT signaling in mammary gland differentiation, cell survival and tumorigenesis. Mol Cell Endocrinol 2014; 382: 560-569.
34. Geymayer S, Doppler W,. Activation of NF-kappaB p50/p65 is regulated in the developing mammary gland and inhibits STAT5-mediated beta-casein gene expression. FASEB J 2000; 14: 1159-1170.
35. Lee HJ, Gallego-Ortega D, Ledger A, et al., Progesterone drives mammary secretory differentiation via RankL-mediated induction of Elf5 in luminal progenitor cells. Development 2013; 140: 1397-1401.
36. Buser AC, Gass-Handel EK, Wyszomierski SL, et al., Progesterone receptor repression of prolactin/signal transducer and activator of transcription 5-mediated transcription of the beta-casein gene in mammary epithelial cells. Mol Endocrinol 2007; 21: 106-125.
37. Nishikawa S, Moore RC, Nonomura N, et al., Progesterone and EGF inhibit mouse mammary gland prolactin receptor and beta-casein gene expression. Am J Physiol 1994; 267: C1467-C1472.
38. Cao Y, Bonizzi G, Seagroves TN, et al., IKKalpha provides an essential link between RANK signaling and cyclin D1 expression during mammary gland development. Cell 2001; 107: 763-775.
39. Jones FE, Welte T, Fu XY, et al., ErbB4 signaling in the mammary gland is required for lobuloalveolar development and Stat5 activation during lactation. J Cell Biol 1999; 147: 77-88.
40. Kabotyanski EB, Rosen JM,. Signal transduction pathways regulated by prolactin and Src result in different conformations of activated Stat5b. J Biol Chem 2003; 278: 17218-17227.
41. Long W, Wagner KU, Lloyd KC, et al., Impaired differentiation and lactational failure of Erbb4-deficient mammary glands identify ERBB4 as an obligate mediator of STAT5. Development 2003; 130: 5257-5268.
42. Thomas E, Lee-Pullen T, Rigby P, et al., Receptor activator of NF-κB ligand promotes proliferation of a putative mammary stem cell unique to the lactating epithelium. Stem Cells 2012; 30: 1255-1264.
43. Chakrabarti R, Wei Y, Romano RA, et al., Elf5 regulates mammary gland stem/progenitor cell fate by influencing notch signaling. Stem Cells 2012; 30: 1496-1508.